[Management of Risk Factors and Comobordities in Atrial Fibrillation].

Atrial fibrillation (AF) is the most common sustained arrhythmia and has gained increasing importance due to demographic changes. The development of AF is multifactorial, including both non-modifiable risk factors such as age and genetic predisposition, as well as modifiable factors like obesity and alcohol consumption. Common comorbidities include arterial hypertension, heart failure, sleep apnea syndrome, and diabetes mellitus. Current studies show that treatment of these risk factors and comorbidities prevents the progression of AF and improves the results of rhythm control therapy. Preventive measures such as weight reduction, physical activity, abstinence and controlling cardiovascular risk factors are important measures to achieve pre-defined therapy goals. Both the German and European AF-guidelines advocate for a comprehensive treatment approach, incorporating an interdisciplinary strategy that fosters collaboration across multiple specialties to effectively treat risk factors and comorbidities.